Evidence map›Paper›PMID 37646506›Full record

ArticlemBio2023

Rapid and strain-specific resistance evolution of

Selina Niggli, Lukas Schwyter, Lucy Poveda, Jonas Grossmann, Rolf Kümmerli

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Proanthocyanidins inhibit methicillin-resistantCurrent research in food science · 2026
    Article
  3. Frontiers in cellular and infection microbiology · 2026
    Article
  4. Article
  5. Journal of bacteriology · 2025
    Article
  6. Review
  7. Article
  8. NorA and Tet38 efflux pumps enableAntimicrobial agents and chemotherapy · 2025
    Article
  9. Article
  10. MvfR ShapesCells · 2025
    Article
  11. Article
  12. Article
  13. Phenazine-1 carboxylic acid ofAntimicrobial agents and chemotherapy · 2024
    Article
  14. Mutations in thebioRxiv : the preprint server for biology · 2024
    Article
  15. Experimentally evolvedMicrobiology (Reading, England) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Selina NiggliDepartment of Quantitative Biomedicine, University of Zurich , Winterthurerstrasse, Zurich, Switzerland.ORCID 0000-0002-1898-4488
Lukas SchwyterDepartment of Quantitative Biomedicine, University of Zurich , Winterthurerstrasse, Zurich, Switzerland.ORCID 0000-0003-2063-6404
Lucy PovedaFunctional Genomics Center Zurich, ETH Zurich and University of Zurich , Winterthurerstrasse, Zurich, Switzerland.ORCID 0000-0002-5291-5582
Jonas GrossmannFunctional Genomics Center Zurich, ETH Zurich and University of Zurich , Winterthurerstrasse, Zurich, Switzerland.ORCID 0000-0002-6899-9020
Rolf KümmerliDepartment of Quantitative Biomedicine, University of Zurich , Winterthurerstrasse, Zurich, Switzerland.ORCID 0000-0003-4084-6679
University of Zurich · CHSIB Swiss Institute of Bioinformatics · CH

Funding

European Research CouncilSwiss National Science Foundation 31003A_182499
6 · The paper itself

Abstract

importancePolymicrobial infections are common. In chronic infections, the different pathogens may repeatedly interact, which could spur evolutionary dynamics with pathogens adapting to one another. Here, we explore the potential of

Indexed as

Pseudomonas InfectionsStaphylococcal InfectionsBiofilmsHumansMicrobial InteractionsPseudomonas aeruginosaStaphylococcus aureuscompetitionmicrobe-microbe interactionsnosocomial pathogenpathogen evolutionpolymicrobial infectionsresistance evolution

Identifiers

PMID37646506
PMCPMC10653847
OpenAlexW4386272599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.